Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on: March 06,2024

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on:March 06,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Updated on: August 27,2024

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Updated on:August 27,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024

Permanent hair dye and straighteners may increase breast cancer risk

by National Institutes of HealthThe study found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don't use t

Updated on: May 11,2024

Permanent hair dye and straighteners may increase breast cancer risk

by National Institutes of HealthThe study found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don't use t

Updated on:May 11,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on: February 18,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on:February 18,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024

Starving cancer cells of fat may improve cancer treatment

byVan Andel Research InstituteLipid limitation decreases levels of storage lipids and increases levels of some PUFA-containing PEs and PCs. Credit:Cell Chemical Biology(2024). DOI: 1

Updated on: November 11,2024

Starving cancer cells of fat may improve cancer treatment

byVan Andel Research InstituteLipid limitation decreases levels of storage lipids and increases levels of some PUFA-containing PEs and PCs. Credit:Cell Chemical Biology(2024). DOI: 1

Updated on:November 11,2024

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on: December 25,2023

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on:December 25,2023

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Updated on: September 27,2024

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Updated on:September 27,2024

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024

New PET/MRI probe promises early discovery of covert diseases

byInstitute of Organic Chemistry and Biochemistry of the CASCurrent PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consis

Updated on: September 15,2024

New PET/MRI probe promises early discovery of covert diseases

byInstitute of Organic Chemistry and Biochemistry of the CASCurrent PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consis

Updated on:September 15,2024